168638 research outputs found
Sort by
Yellow fever, Zika virus disease, non-congenital (Week 33) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents weeks ending August 17, 2019
No full textThis data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Yellow fever, Zika virus disease, non-congenital cases. The weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/2019-33-Table1pp -H.pd
Mumps; Novel influenza A virus infections (Week 34) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents weeks ending August 24, 2019
No full textThis data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Mumps; Novel influenza A virus infections cases. The weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/2019-34-Table1y -H.pd
Use of Family Planning Services by Currently Married Women 15-44 Years of Age: United States, 1973 and 1976
Get PDFAbout 13,300,000 currently married women received professional family planning services during the 3 years before the 1976 National Sur\uadvey of Family Growth, an increase of about 1 million, or 8 percent, above the number who made a family planning visit in the 3 years before a similar survey conducted in 1973.Among fecund, or nonsterile, couples about 57.9 percent made a family planning visit in the 3-year period prior to the 1976 survey as compared with 51.2 percent in the 3-year period prior to 1973.Among wives who reported making a family planning visit in the 3 years before the 1976 survey, a large majority (W percent) reported their most recent visit was with their own physician, while a minority (16 percent) indicated the last visit was with an organized medical service. These figures are not significantly dif\uad ferent from the comparable figures for 1973.The statistics on use of family planning services are from the National Survey of Family Growth, Cycles I and II, conducted by the National Center for Health Statistics. Data were collected through personal interviews with amultistage, probability sample of women in the household population of the conterminous United States. Women 15-44 years of age, inclusive, who were currently married or previously married or who were never married but had offspring presently living in the household were eligible for inclusion in the sample
Hemolytic uremic syndrome post-diarrheal; Hepatitis (viral, acute, by type) (Week 34) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents weeks ending August 24, 2019
No full textThis data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Hemolytic uremic syndrome post-diarrheal; Hepatitis (viral, acute, by type) cases. The weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/2019-34-Table1p -H.pd
Int J Toxicol
Get PDFRespiratory exposure to multiwalled carbon nanotubes (MWCNT) or asbestos results in fibrosis; however, the mechanisms to reach this end point may be different. A previous study by our group identified pulmonary effects and significantly altered messenger RNA (mRNA) signaling pathways following exposure to 1, 10, 40, and 80 \ub5g MWCNT and 120 \ub5g crocidolite asbestos on mouse lungs over time at 1-month, 6-month, and 1-year postexposure following pulmonary aspiration. As a continuation to the above study, this current study took an in-depth look at the signaling pathways involved in fibrosis development at a single time point, 1 year, and exposure, 40 \ub5g MWCNT, the lowest exposure at which fibrosis was pathologically evident. The 120 \ub5g asbestos exposure was included to compare MWCNT-induced fibrosis with asbestos-induced fibrosis. A previously validated computational model was used to identify mRNAs with expression profiles matching the fibrosis pathology patterns from exposed mouse lungs. mRNAs that matched the pathology patterns were then input into ingenuity pathway analysis to determine potential signaling pathways and physiological disease functions inherent to MWCNT and asbestos exposure. Both MWCNT and asbestos exposure induced changes in mouse lungs regarding gene expression, cell proliferation, and survival, while MWCNT uniquely induced alterations in pathways involved in oxidative phosphorylation, mitochondrial dysfunction, and transcription. Asbestos exposure produced unique alterations in pathways involved in sustained inflammation. Although typically considered similar due to scale and fiber-like appearance, the different compositional properties inherent to either MWCNT or asbestos may play a role in their ability to induce fibrosis after pulmonary exposure.CC999999/ImCDC/Intramural CDC HHS/United StatesR01 ES021764/ES/NIEHS NIH HHS/United StatesP20 GM103434/GM/NIGMS NIH HHS/United State
Viral hemorrhagic fevers (Week 32) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents weeks ending August 10, 2019
No full textThis data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases. The weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/2019-32-Table1mm -H.pd
J Assoc Nurses AIDS Care
Get PDFCC999999/ImCDC/Intramural CDC HHS/United StatesU2G GH000994/GH/CGH CDC HHS/United State
Spotted fever rickettsiosis; Smallpox (Week 33) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents weeks ending August 17, 2019
No full textThis data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Spotted fever rickettsiosis; Smallpox cases. The weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/2019-33-Table1gg -H.pd
Carbapenemase-producing carbapenem-Resistant Enterobacteriaceae: (Week 34) Weekly cases* of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending August 24, 2019
No full textThis data includes weekly cases of notifiable diseases for the United States, U.S. Territories, and Non-U.S. Residents, specifically covering Carbapenemase-producing carbapenem-Resistant Enterobacteriaceae cases. The weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov